MedTrace Logo

Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery

NCT06483698 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2025-08-29

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of early-stage lung cancer patients who have received surgery using the real-world data. The main questions it aims to answer are:

* What is the best surgical strategy for patients with early-stage lung cancer?
* What are the risk factors for early-stage lung cancer? Participants will receive surgery and the study will analyze the real-world data.

Conditions

Interventions

OTHER

Sublobar resection

Sublobar resection is a series of surgical approaches for lung cancer.

OTHER

Lobectomy

Lobectomy is the surgical approach for lung cancer.

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Shugeng Gao, MD · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2026-03-31
Completion
2034-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06483698 on ClinicalTrials.gov